Clinical Trials Contact

About this Clinical Trial

A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

Your Message Will Go To

Zeel Patel

650-736-2563


All fields are required. *

Preferred contact method*

To:

Zeel Patel

650-736-2563



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine